Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
astrazeneca
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech
clinical trials
deals
fda
finch therapeutics
gene therapy
johnson & johnson
microbiome
pfizer
What
bio
roundup
acquisitions
alzheimer’s
august
biggest
biotech
build
busy
buy
ceo
company’s
congress
daniel
days
debut
decisions
democrats
devices
divided
drug
drugs
dyne’s
elections
fallout
fda
gilead
legacy
losses
microbiome
midterm
moves
news
nods
openly
opioid
o’day
panel
past
pipeline
Language
unset
Current search:
astrazeneca
×
amgen
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
